{
    "name": "technetium Tc 99m succimer",
    "comment": "Rx",
    "other_names": [
        "Nephroscan"
    ],
    "classes": [
        "Diagnostic Imaging Agents"
    ],
    "source": "https://reference.medscape.com/drug/nephroscan-technetium-tc-99m-succimer-4000285",
    "pregnancy": {
        "common": [
            "Insufficient data are available use in pregnant females to evaluate for a drug-associated risk of major birth defects and miscarriage"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Studies have not been conducted",
                    "Although all radiopharmaceuticals may potentially cause fetal harm depending on fetal stage of development and magnitude of the radiation dose, radiation exposure to fetus from technetium Tc 99m succimer is expected to be low (<0.50 mGy)"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Present in breast milk",
            "There are no data on effects of technetium Tc 99m succimer on breastfed infants or effects on milk production",
            "Use for imaging in infants with renal disease; exposure to technetium Tc 99m succimer via breast milk is expected to be lower.",
            "Advise lactating females to temporarily discontinue breastfeeding and to pump and discard breast milk for a minimum of at least 24 hr after administration",
            "Consider developmental and health benefits of breastfeeding along with a mother’s clinical need, any potential adverse effects on the breastfed child from technetium Tc 99m succimer or from the underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Hypersensitivity reactions, including urticaria, rash, pruritus, erythema reported; onset of reactions varied within 2 hr to several hr after injection; monitor for hypersensitivity reactions and always have cardiopulmonary resuscitation equipment and personnel available",
                "Technetium Tc 99m contributes to a patient’s overall long-term cumulative radiation exposure; long-term cumulative radiation exposure is associated with an increased risk of cancer; ensure safe handling and preparation reconstitution procedures to protect patients and health care workers from unintentional radiation exposure; encourage patients to drink fluids and void as frequently as possible after administration",
                "Use in patients with severely reduced eGFR may influence image interpretation as the kidneys may not absorb the technetium Tc 99m succimer and thus may distribute to organs or parts of the body other than kidneys; satisfactory images may be obt"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Immune system disorders",
            "percent": null
        },
        {
            "name": "Hypersensitivity including urticaria",
            "percent": null
        },
        {
            "name": "rash",
            "percent": null
        },
        {
            "name": "pruritus",
            "percent": null
        },
        {
            "name": "and erythema",
            "percent": null
        },
        {
            "name": "General disorders",
            "percent": null
        },
        {
            "name": "syncope",
            "percent": null
        },
        {
            "name": "fever",
            "percent": null
        },
        {
            "name": "and nausea",
            "percent": null
        }
    ]
}